Related Experiment Video
Updated: Aug 7, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Revisiting the Mesenchymal "Stem vs. Stromal" Cell Dichotomy and Its Implications for Development of Improved Potency
Donald G Phinney1, Ryang Hwa Lee2, Siddaraju V Boregowda1
1Department of Molecular Medicine, Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL, USA.
Abstract:
Mesenchymal stem/stromal cell (MSC)-based therapies have been evaluated in over 1500 human clinical trials for a diverse array of disease indication, but outcomes remain unpredictable due to knowledge gaps in the quality attributes that confer therapeutic potency onto cells and their mode of action in vivo. Based on accumulated evidence from pre-clinical models, MSCs exert therapeutic effects by repressing inflammatory and immune-mediated response via paracrine action following reprogramming by the host injury microenvironment, and by polarization of tissue resident macrophages following phagocytosis to an alternatively activated (M2) state. An important tenet of this existing paradigm is that well-established stem/progenitor functions of MSCs are independent of paracrine function and dispensable for their anti-inflammatory and immune suppressive functions. Herein, we review evidence that stem/progenitor and paracrine functions of MSCs are mechanistically linked and organized hierarchically and describe how this link may be exploited to develop metrics that predict MSC potency across a spectrum of activities and regenerative medicine applications.
Insights
Mesenchymal stem/stromal cell (MSC) therapies show unpredictable outcomes. This review reveals linked stem and paracrine functions, offering a way to predict MSC therapeutic potency for regenerative medicine.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Immunology
Background:
- Mesenchymal stem/stromal cell (MSC)-based therapies are in over 1500 clinical trials, yet their efficacy is unpredictable.
- Current understanding suggests MSCs modulate inflammation and immunity via paracrine actions and macrophage polarization.
- A key assumption is that MSC stem/progenitor functions are separate from their therapeutic immune-modulatory effects.
Approach:
- This review synthesizes pre-clinical evidence on MSC mechanisms of action.
- It examines the relationship between MSC stem/progenitor functions and their paracrine activities.
- The review proposes a hierarchical organization of these functions.
Key Points:
- Evidence suggests MSC stem/progenitor and paracrine functions are mechanistically linked.
- These functions appear to be organized hierarchically, not independently.
- This linkage offers a potential basis for developing predictive potency assays.
Conclusions:
- Understanding the integrated nature of MSC functions is crucial for improving therapeutic outcomes.
- Exploiting the link between stem and paracrine functions can lead to better MSC potency metrics.
- This approach may enhance the predictability and application of MSCs in regenerative medicine.
More Related Videos
Related Concept Videos
Source And Potency Of Stem Cells
Mesenchymal Stem Cells
Multipotency of Hematopoietic Stem Cells
Stem Cell Culture
Multipotency and Niche of Bulge Stem Cell

